Skip to main content

November/December 2009, Vol 2, No 7

Editorial
Wellness and the Governing Dynamics of Healthcare Reform
Robert E. Henry
Read More
Perspectives
Doctors on Healthcare Reform
Betsy McCaughey
Read More
Business
Health Plan Retention and Pharmacy Costs of Newly Diagnosed Patients with Chronic Kidney Disease in a Managed Care Population
Maureen Kubacki, PharmD, MBA , Chureen Carter, PharmD, MS , Alan D. L. Herrera, PharmD, Jim Wang, PhD, Janice M.S. Lopez, PharmD, MPH, Catherine T. Piech, MBA
Stakeholder Perspective
Alignment of Incentives along the Healthcare Payer Continuum for Patients with Kidney Disease
by Jeff Januska, PharmD
Read More
Regulatory
Quality Improvement Initiatives: The Missed Opportunity for Health Plans
Sara Fernandez-Lopez, PhD, Jeffrey A. Bourret, PharmD, Barbara Lennert, RN, BSN, MAOM
Stakeholder Perspective
The Missing Quality Standard for Medication Adherence
Read More
Clinical
Economic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic Rhinitis
Kim Saverno, PhD, Brian Seal, PhD, Michael J. Goodman, PhD, Kellie Meyer, PharmD
Stakeholder Perspective
Allergic Rhinitis: A Serious Condition with Many Safe and Effective Pharmaceutical Options
by Paul Anthony Polansky, BSPharm, MBA
Read More
Industry Trends
Increases in Drug Utilization and Patent Expirations: A Recipe for Growth of Generics' Market Share, despite Stalling on Biosimilars
Dalia Buffery, MA, ABD
Read More
Industry Trends
Management Tools for Molecular Diagnostic Testing: Financial and Clinical Implications
Douglas Moeller, MD
Read More

Results 1 - 7 of 7